A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer
Conditions: Head and Neck Cancer; Esophageal Cancer; Otorhinolaryngologic Neoplasms; Ear Cancer; Nose Cancer; Laryngeal Cancer; Pharyngeal Cancer Intervention: Drug: Recombinant oncolytic herpes simplex virus type 1 (R130) Sponsors: Shanghai Yunying Medical Technology; Eye & ENT Hospital of Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2023 Category: Research Source Type: clinical trials
A 48 Week Observational Study of the Frequency of Symptomatic Herpes Virus I and II in HIV Infected Subjects
Conditions: HIV Disease; Herpes Simplex 1; Herpes Simplex 2 Intervention: Other: Blood draw Sponsors: Global Research Institute; Rational Vaccines Inc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 21, 2023 Category: Research Source Type: clinical trials
